Dear Editor,

The case series published so far are quite heterogeneous \[[@bib0005], [@bib0010], [@bib0015]\]. Some series occurred during the beginning of the pandemic, when the disease was largely unknown, others occurred during the peak of mortality and fear of disease spread among the community and healthcare professionals; some series pertained to symptomatic women in settings where testing was only performed in cases with moderate to severe symptoms and others also to asymptomatic women in settings where large scale testing had been done; some cases were uneventful, others had poor outcome.

We report a case series from an universally tested population from Hospital Pedro Hispano, located in the most affected region of Portugal with COVID-19 \[[@bib0020]\].

From March 25 to April 15, all the 103 pregnant women admitted to our department were tested for SARS-CoV-2. Twelve cases (11,7 %) were positive, 11 of which were asymptomatic. From these, 10 had delivered by now, 6 by cesarean section and 4 vaginally. Gestational ages, 5 min Apgar scores and newborn weights ranged between 37--41 weeks, 9--10 and 2350--3380 g, respectively. Eight cases had mild fetal growth restriction and there was one delivery of twins. There were no maternal complications and all the newborns tested negative ([Table 1](#tbl0005){ref-type="table"} ).Table 1Summary of maternal characteristics, symptoms and delivery details of pregnant women with SARS-Cov-2 infection. Abbreviations: SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; RT‐PCR, reverse transcription polymerase chain reaction.Table 1PatientAgeGestational age at diagnosis (weeks)Maternal comorbid conditionsSymptomsMode of deliveryFetus Weight (grams), Apgar score (1 min/5 min)Neonatal SARS-Cov-2 rt-PCRObservations**1**2235NoneNo------Fetal Growth Restriction**2**4130Ulcerative colitis, Psoriasis\
(chronic corticotherapy)No------Preterm Premature Rupture of Membranes.**3**3637Severe Scoliosis, Behçet SyndromeHeadacheCesarean2350 g, 9/10NegativeFetal Growth Restriction**4**3839NoneNoCesarean2480 g, 9/10NegativeGestational Diabetes, Fetal Growth Restriction**5**2741NoneNoCesarean3380 g, 9/10Negative**6**3237NoneNoVaginal2600 g, 8/9NegativeGestational Hypertension**7**3340Severe myopiaNoCesarean2670 g, 9/10NegativeFetal Growth Restriction**8**3440NoneNoVaginal2795 g, 9/10NegativeFetal Growth Restriction**9**3537Asthma, Raynaud SyndromeNoVaginal2410 g, 9/10NegativeFetal Growth Restriction**10**2739NoneNoVaginal3220 g, 9/10Negative**11**2938Chronic HypertensionNoCesarean2580 g, 9/10NegativeFetal Growth Restriction**12**2937NoneNoCesarean2370, 9/10\
2745 g, 9/10Negative\
NegativeDichorionic Diamniotic Pregnancy\
Fetal growth discordance

Our series shows that most cases are asymptomatic. Not surprisingly, the prognosis was good in all our cases, as women had minimal or no signs of disease. Apparently, there is no relation between COVID-19 and our growth restricted fetuses, having in mind the chronology of the events.

At the time of our first delivery, Portugal had decided to follow the most restrictive guidelines ultimately developed by Chinese experts \[[@bib0020],[@bib0025]\]. The country was warned by the Italian and Spanish situations, where a devastating pandemic had started two weeks before and universal testing in hospital admissions was decided to allow early diagnosis and identification of potential spreaders of the disease.

It is not yet known what is the best strategy to address COVID-19 during pregnancy and labor. However, it is quite clear that we do need to consider not only epidemiological and clinical factors, but also organizational, social and political issues. Last but not least, universal testing of all the admitted pregnant women is an unique opportunity to have an idea of the prevalence among the population (11,7 % in our series).
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